TR201901905T4 - Kuru kaplanmış ağızda dağılan tablet. - Google Patents

Kuru kaplanmış ağızda dağılan tablet. Download PDF

Info

Publication number
TR201901905T4
TR201901905T4 TR2019/01905T TR201901905T TR201901905T4 TR 201901905 T4 TR201901905 T4 TR 201901905T4 TR 2019/01905 T TR2019/01905 T TR 2019/01905T TR 201901905 T TR201901905 T TR 201901905T TR 201901905 T4 TR201901905 T4 TR 201901905T4
Authority
TR
Turkey
Prior art keywords
inner core
tablet
dry coated
orodispersible tablet
press
Prior art date
Application number
TR2019/01905T
Other languages
English (en)
Inventor
Ikeda Yuki
Ochiai Yasushi
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Publication of TR201901905T4 publication Critical patent/TR201901905T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Abstract

Buluşun amacı, bir bütün tablet olarak mükemmel bir dağılabilirliğe ve uygun bir sertliğe sahip, iç çekirdeğinde zayıf şekillenebilirliğe sahip bir toz/granüler malzemeye sahip pres ile kaplanmış ağızda dağılan bir tablet sağlamaktır. Ayrıca buluş, bir iç çekirdeği kaplayan bir dış katmana sahip pres ile kaplanmış ağızda dağılan bir tablettir, burada iç çekirdek, tabletin bütünü için %30 ila 80 aralığında bir kalınlığa sahiptir, ve dış katman (a) mikrokristalin selüloz, (b) bir şeker veya bir şeker alkolü, ve (c) krospovidon, nişastalar, düşük ikameli hidroksipropilselüloz ve karmelozdan oluşan gruptan seçilen bir veya daha fazla belirli içerik maddesi içermektedir.
TR2019/01905T 2009-12-11 2010-12-10 Kuru kaplanmış ağızda dağılan tablet. TR201901905T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009281216 2009-12-11

Publications (1)

Publication Number Publication Date
TR201901905T4 true TR201901905T4 (tr) 2019-03-21

Family

ID=44145682

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/01905T TR201901905T4 (tr) 2009-12-11 2010-12-10 Kuru kaplanmış ağızda dağılan tablet.

Country Status (9)

Country Link
US (1) US9278063B2 (tr)
EP (1) EP2510950B1 (tr)
JP (1) JP5702305B2 (tr)
KR (1) KR101907218B1 (tr)
CN (1) CN102740893B (tr)
DK (1) DK2510950T3 (tr)
ES (1) ES2713330T3 (tr)
TR (1) TR201901905T4 (tr)
WO (1) WO2011071139A1 (tr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6245677B2 (ja) * 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
JP2015537013A (ja) * 2012-11-19 2015-12-24 アサンタ・アー／エス 速崩性錠剤
KR101352689B1 (ko) 2012-12-31 2014-01-17 (주) 에프엔지리서치 불연속상과 연속상으로 이루어지는 응집단위를 포함하는 마이크로그래뉼 제형
JP6341196B2 (ja) * 2013-03-21 2018-06-13 大正製薬株式会社 固形製剤
US20160051478A1 (en) * 2013-03-29 2016-02-25 Roquette Freres Film-forming compostions for the film-coating of solid forms
US20160136091A1 (en) 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet
WO2015038854A1 (en) 2013-09-13 2015-03-19 R.P. Scherer Technologies, Llc Encased-pellet tablets
US11033500B2 (en) * 2015-10-02 2021-06-15 Dsm Ip Assets B.V. Process for the production of compressed tablets
WO2017064815A1 (ja) * 2015-10-16 2017-04-20 持田製薬株式会社 低用量薬物を含有する口腔内崩壊錠
JP6606287B2 (ja) 2016-07-27 2019-11-13 沢井製薬株式会社 口腔内崩壊錠添加用組成物
WO2018047789A1 (ja) 2016-09-06 2018-03-15 沢井製薬株式会社 口腔内崩壊錠添加用組成物
KR102055667B1 (ko) * 2018-01-19 2019-12-13 김한수 젤리 정제형 치약 조성물 및 그 제조방법
JP2023549848A (ja) * 2020-11-13 2023-11-29 シーラ エスアールエル ｎ－酪酸のエステルまたは塩を含有する口腔内分散性化合物、およびその製造プロセス
CN113476417A (zh) * 2021-08-12 2021-10-08 郑州味千生物技术有限公司 一种口腔崩解片掩味外层及制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
JP3317444B2 (ja) 1989-07-20 2002-08-26 大日本製薬株式会社 不快な味が遮蔽された速放性製剤
EP0922464B1 (en) * 1996-07-12 2005-03-30 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
EP0839526A3 (en) 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
JPH10182436A (ja) * 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JP3447042B2 (ja) 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AU5248900A (en) 1999-06-18 2001-01-09 Takeda Chemical Industries Ltd. Quickly disintegrating solid preparations
JP2001058944A (ja) 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
EP1302304B1 (en) 2000-06-20 2011-12-14 Sanwa Kagaku Kenkyusho Co., Ltd. Method of producing a nucleated molded article
MXPA02012640A (es) * 2000-06-20 2004-09-10 Sanwa Kagaku Kenkyusho Co Piezas moldeadas que tienen nucleo y metodos y aparato para fabricarlas.
JP4438268B2 (ja) 2001-03-07 2010-03-24 大日本住友製薬株式会社 薬物顆粒の製造方法、および薬物顆粒、ならびにそれを用いた医薬製剤
KR20040037138A (ko) * 2001-09-28 2004-05-04 가부시키가이샤산와카가쿠켄큐쇼 유핵형 속용붕괴성 성형품
JP2005517690A (ja) * 2002-02-01 2005-06-16 ファイザー・プロダクツ・インク 固体薬物分散物を含有する即時放出剤形
JP4740740B2 (ja) 2003-12-09 2011-08-03 大日本住友製薬株式会社 薬物含有粒子および該粒子を含む固形製剤
WO2005097041A1 (ja) 2004-04-09 2005-10-20 Sanwa Kagaku Kenkyusho Co., Ltd. 有核成型品とその製造方法
JP4439499B2 (ja) 2005-08-01 2010-03-24 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠

Also Published As

Publication number Publication date
JP5702305B2 (ja) 2015-04-15
CN102740893A (zh) 2012-10-17
EP2510950B1 (en) 2018-11-28
DK2510950T3 (en) 2019-03-04
EP2510950A1 (en) 2012-10-17
WO2011071139A1 (ja) 2011-06-16
US20120237602A1 (en) 2012-09-20
KR20120117985A (ko) 2012-10-25
CN102740893B (zh) 2014-07-23
KR101907218B1 (ko) 2018-10-11
JPWO2011071139A1 (ja) 2013-04-22
ES2713330T3 (es) 2019-05-21
US9278063B2 (en) 2016-03-08
EP2510950A4 (en) 2013-11-06

Similar Documents

Publication Publication Date Title
TR201901905T4 (tr) Kuru kaplanmış ağızda dağılan tablet.
AR114143A2 (es) Formulaciones de comprimidos revestidos
MX345777B (es) Formulaciones de tabletas bicapa.
CL2008002486A1 (es) Comprimido divisible de liberacion modificada que comprende glicazida, un derivado de celulosa elegido entre: hmc, hec, hpc y/o hpmc y un aglutinante elegido entre: maltodextrina, polividona o hpmc; uso para tratar diabetes.
WO2009061746A3 (en) Process for integrating cellulose and starch feedstocks in ethanol production
FI20106121L (fi) Soluviljelymateriaali
TR201901182T4 (tr) Hidrokoloid olarak nişasta türevleri içeren bir renklendirme kompozisyonu.
MX347489B (es) Fideos secos y método para producir los mismos.
BRPI0822026A2 (pt) Prepação farmacêutica ou nutracêutica revestida com liberação acentuada de substância ativa no cólon.
WO2009061221A3 (en) Agent stabilisation process and product
EA201100316A1 (ru) Новая крахмальная композиция и способ производства выпеченных изделий
HK1176304A1 (en) Flat cellulose powder processed with amphiphilic substance, and cosmetic preparation containing same
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2008003230A1 (es) Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
EP2560642A4 (en) TREATMENT OF GICHT
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
FI20070395A (fi) Fotokatalyyttisesti aktiivinen koostumus ja menetelmä sen valmistamiseksi
WO2010030835A3 (en) Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
DE602008000367D1 (de) Valsartanformulierungen
MX2014014811A (es) Materiales comestibles y su elaboracion.
EP1968559A4 (en) INFLAMMATORY BOTANICAL PRODUCTS FOR THE TREATMENT OF METABOLIC SYNDROME AND DIABETES
ZA200605004B (en) Use of corn with low gelatinization temperature for production of fermentation-based products
BR112022011271A2 (pt) Célula hospedeira recombinante, composição, métodos para produzir um derivado de uma célula e um produto de fermentação, e, uso de uma célula hospedeira recombinante
EA201001032A1 (ru) Таблетки с пленочным покрытием, содержащие в качестве активного компонента дроспиренон, и способ их получения
EP4056637A4 (en) CELLULOSE COMPOSITION AND TABLET